Does CELECOXIB Cause Second primary malignancy? 17 Reports in FDA Database
Grow Your Own Natural Pharmacy at Home
Medicinal Garden Kit — 10 healing herbs, 4,818 seeds + step-by-step guide.
According to the FDA Adverse Event Reporting System (FAERS), 17 reports of Second primary malignancy have been filed in association with CELECOXIB (Celecoxib). This represents 0.1% of all adverse event reports for CELECOXIB.
17
Reports of Second primary malignancy with CELECOXIB
0.1%
of all CELECOXIB reports
16
Deaths
11
Hospitalizations
How Dangerous Is Second primary malignancy From CELECOXIB?
Of the 17 reports, 16 (94.1%) resulted in death, 11 (64.7%) required hospitalization.
Is Second primary malignancy Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for CELECOXIB. However, 17 reports have been filed with the FAERS database.
What Other Side Effects Does CELECOXIB Cause?
Drug ineffective (8,188)
Drug hypersensitivity (5,314)
Pain (4,248)
Rheumatoid arthritis (3,789)
Off label use (3,782)
Arthralgia (3,766)
Nausea (3,497)
Fatigue (3,235)
Condition aggravated (3,060)
Diarrhoea (3,017)
What Other Drugs Cause Second primary malignancy?
CYCLOPHOSPHAMIDE (1,247)
DOXORUBICIN (1,151)
VINCRISTINE (908)
IMATINIB (763)
PALBOCICLIB (658)
RITUXIMAB (646)
RUXOLITINIB (611)
ETOPOSIDE (573)
PREDNISONE (517)
OCTREOTIDE (496)
Which CELECOXIB Alternatives Have Lower Second primary malignancy Risk?
CELECOXIB vs CELIPROLOL
CELECOXIB vs CELLCEPT
CELECOXIB vs CEMIPLIMAB
CELECOXIB vs CEMIPLIMAB-RWLC
CELECOXIB vs CENEGERMIN-BKBJ